Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2026

VOLUNTARY ANNOUNCEMENT LATEST BUSINESS DEVELOPMENTS

VOLUNTARY ANNOUNCEMENT COMPREHENSIVE UPGRADE OF SPEECH LARGE LANGUAGE MODELS U2-ASR AND U2-TTS

VOLUNTARY ANNOUNCEMENT IN RELATION TO THE INCREASE IN H SHAREHOLDING BY THE CONTROLLING SHAREHOLDER, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR

VOLUNTARY ANNOUNCEMENT INTENTION TO REPURCHASE SHARES ON THE MARKET

REVENUE FORECAST FOR THE FIRST HALF OF 2026

VOLUNTARY ANNOUNCEMENT SIGNED MULTIPLE LLM PROJECTS AT GRADE 3 CLASS A HOSPITALS

VOLUNTARY ANNOUNCEMENT LAUNCH OF THE U2-MED TRI-MEDICAL LLM

POLL RESULTS OF THE 2026 SECOND EXTRAORDINARY GENERAL MEETING

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026

DISCLOSEABLE TRANSACTION GENERAL CONTRACTING ENGINEERING CONTRACT

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

RESIGNATION OF NON-EXECUTIVE DIRECTOR

POLL RESULTS OF THE 2025 AGM

Rules of the Restricted H Share Incentive Scheme

PROXY FORM FOR THE 2026 SECOND EXTRAORDINARY GENERAL MEETING

NOTICE OF THE 2026 SECOND EXTRAORDINARY GENERAL MEETING

(1) PROPOSED ADOPTION OF THE RESTRICTED H SHARE INCENTIVE SCHEME; (2) PROPOSED MANDATE TO THE BOARD AND/OR THE COMMITTEE TO HANDLE MATTERS PERTAINING TO THE RESTRICTED H SHARE INCENTIVE SCHEME; AND NOTICE OF THE 2026 SECOND EXTRAORDINARY GENERAL MEETING

VOLUNTARY ANNOUNCEMENT LATEST BUSINESS DEVELOPMENTS

PROXY FORM FOR THE 2025 ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 26, 2026